Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Luminal Stents

Research Leaders

7 sponsors active, led by American Society of Colon and Rectal Surgeons

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Luminal Stents1
  • Minimally Invasive Surgical Bowel Diversion1
  • Evolutionr Colonic Stent1

Active Sponsors

  • American Society of Colon and Rectal Surgeons1
  • Association of Surgeons of Great Britain and Ireland1
  • Cook Group Incorporated1
  • Memorial Sloan Kettering Cancer Center1
  • European Society for Trauma and Emergency Surgery1

Top Investigators

Related Conditions

  • Colonic Obstruction1
  • Colonic Stricture1

Activity Timeline